HPV vaccine in Brazil reduces genital warts and cervical precancer hospitalizations
HPV vaccination in Brazil led to significant reductions in genital warts and cervical precancer hospitalizations, especially among those under 20 years of age.
Nine-valent HPV vaccination program in Panama promises major public health benefits
Panama’s switch to the 9-valent HPV vaccine promises greater protection and reduced cancer rates, preventing thousands of HPV-related cases and deaths.
Clesrovimab: A potential new player to protect against RSV
Octavio Ramilo, MD, joins us to discuss new clesrovimab phase 2b/3 study data presented at IDWeek 2024 in Los Angeles, California.
IDWeek: Clesrovimab reduces RSV disease, hospitalization in healthy infants
There were no treatment or RSV-related deaths during the study.
What’s new for maternal Group B Streptococcus vaccines?
At IDweek 2023, Flor Munoz, MD, MSc, provided an update on maternal Group B Streptococcus (GBS).
Current and upcoming strategies for prevention of CMV in neonates
Vana Papevangelou, MD, PhD, presented current and upcoming strategies to prevent congenital cytomegalovirus (CMV) infections in neonates at IDWeek 2023.
Genital herpes: expanding the toolbox
For this highly infectious disease, a thoughtful and comprehensive approach to care and treatment are a necessity.
Maternal RSV vaccines: what health care providers should know right now
At IDWeek 2023, a presentation sharing the latest news in RSV vaccines.
The transformative impact of HPV vaccines
At IDWeek 2023, a session on how increased rates of the HPV vaccine have resulted in a decline in certain conditions and disease states.
Ventilator associated infections: what is new in defining, diagnosing, and treating in pediatrics
At IDWeek 2023, a presentation on the challenges to the diagnosis and management of VAIs in children.
Hot topics in diagnosing, preventing, and treating central line associated bloodstream infections
At IDWeek 2023, updates on CLABSIs in the pediatric population.
Understanding post-viral sequelae through the lens of HIV
At IDWeek 2023, a presenter shares his own studies on the impact of viral effects after infection.
Pediatric immunocompromised hosts: a glimpse into the future
At IDWeek 2023, a presenter discusses the future of infection prevention from organ transplants in children.
How effective are maternal influenza vaccines during pregnancy and breastfeeding?
At IDWeek 2023, several authors share a study on mother-infant pairs, evaluating for differences in rates of influenza infections in infants.
Should a lumbar puncture be performed to determine the end of therapy for Gram-negative neonatal meningitis?
At IDWeek 2023, a discussion of the best end of therapy for Gram-negative neonatal meningitis.
TB in pediatric patients is not so wee
At IDWeek 2023, a session on TB, which remains a formidable foe in global pediatric health.
How health care providers can be part of the solution to climate change
At IDWeek 2023, a presentation on the emotional and financial cost of climate change, and what clinicians can do right now to help.
Should neonates with bacteremic UTI be treated with IV only?
At ID Week 2023, 2 health care providers argue the pros and cons of treatments for newborns with bacteremic UTIs.
Mpox: where we were, where we are now
At IDWeek 2023, a White House expert on Mpox discusses initial reactions to the outbreak, vaccination rates, and where we need to do better in combatting this infectious disease.
Elimination means everyone: screening and management of hepatitis C in infants and children
At IDWeek 2023, a presentation on the latest recommendations for screening and management of hepatitis C in the pediatric population.
Charting a future of infectious diseases care with artificial intelligence
At a plenary session at IDWeek 2023, the benefits and challenges of using AI in treating infectious diseases was discussed.
